Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis

Tumor Biology

Volumn 34, Issue 5, 2013, Pages 3049-3057

  Malik, Manzoor Ahmad ^a   Gupta, Annapurna ^a   Zargar, Showkat Ali ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

DCC; Kashmir Valley; Met analysis; PCR RFLP; Polymorphism

Indexed keywords

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DELETED IN COLORECTAL CARCINOMA GENE; ESOPHAGUS CANCER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HISTOPATHOLOGY; HUMAN; INDIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SALTED TEA; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STOMACH ADENOCARCINOMA; STOMACH CANCER; TEA;

EID: 84885419010     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0870-4     Document Type: Article

References (36)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594-606.
2. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102-11.
3. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33:11-5.
4. Siddiqi M, Kumar R, Fazili Z, Spiegelhalder B, Preussmann R. Increased exposure to dietary amines and nitrate in a population at high risk of oesophageal and gastric cancer in Kashmir (India). Carcinogenesis. 1992;13:1331-5.
5. Siddiqiz M, Tricker AR, Preussmann R. The occurrence of preformed N nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir India. Cancer Lett. 1988;39:37-43.
6. Malik MA, Zargar SA, Mittal B. Role of NQO1 609C>T and NQO2-3423G>A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39(9):9095-104.
7. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009;40:26-32.
8. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, et al. The DCC gene: structural analysis and mutations in colorectal carcinomas. Vogelstein B Genomics. 1994;19(3):525-31.
9. Krimpenfort P, Song JY, Proost N, Zevenhoven J, Jonkers J, Berns A. Deleted in Colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature. 2012;482(7386):538-41. doi: 10.1038/nature10790.
10. Maran S. Lee YY, Xu S, Rajab NS, Hasan N, Mustaffa N et al. Deleted in Colorectal Cancer (DCC) Gene Polymorphism is associated with H. pylori infection among susceptible Malays from the North-Eastern Region of Peninsular Malaysia. Hepatogastroenterology. 2012;Jul 25;60(121). doi: 10.5754/hge12471.
11. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247:49-56.
12. Fearon ER, Vogelste B. A genetic mode l for colorectal tumorigenesis. Cell. 1990;61:759-67.
13. Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, et al. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer. 1993;53:260-3.
14. Reale MA, Hu G, Zafar AI, Getzenberg RH, Levine SM, Fearon ER. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 1994;54:4493-501.
15. Fearon ER. DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta. 1996;9(1288):M17-23.
16. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele Jr G, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med. 1996;335(23):1727-32.
17. Sun XF, Rütten S, Zhang H, Nordenskjöld B. Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma. J Clin Oncol. 1999;17:1745-50.
18. Toma M, Stavarachi M, Cimponeriu D, Apostol P, Cojocaru M, Belusica L et al. P53 And DCC Polymorphisms and the risk for colorectal cancer in Romanian patients - a preliminary study. Tom. XVI / 2, 2009, pp. 162-165.
19. Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura YJ. A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. Hum Genet. 2012;57(4):235-7. doi: 10.1038/jhg.2012.9.
20. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B. DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: GENE-D-12-01446). Gene. 2013;2013 Jan 23.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
22. Carlson JM, Heckerman D, Shani G. Estimating false discovery rates for contingency tables. Microsoft research technical report. 2009 MSR-TR-2009-53. http://research.microsoft.com/en-us/um/redmond/projects/MSCompBio/ FalseDiscovery Rate/
23. Comprehensive meta-analysis version 2.0. http://www.meta-analysis.com/
24. Mattar R, Nonogaki S, Silva C, Alves V, Gama-Rodrigues JJ. P53 and Rb tumor suppressor gene alterations in gastric cancer. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(4):172-80.
25. Schmitt CA, Thaler KR, Wittig BM, Kaulen H, Büschenfelde CKMZ, Dippold WG. Detection of the DCC gene product in normal and malignant colorectal tissues and its related to a codon 201 mutation. Br J Cancer. 1998;77:588-94.
26. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992;52:3099-102.
27. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 1992;52(23):6525-30.
28. Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene. 1991;6(2):311-5.
29. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723-7.
30. Höhne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992;52(9):2616-9.
31. Scheck AC, Coons SW. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993;53:5605-9.
32. Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol. 1998;51:593-6.
33. Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest. 1996;74:835-41.
34. Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, et al. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197:44-50.
35. Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, et al. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol. 2008;23:948-53.
36. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004;431:80-4.